This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Dec 12;55(11):1600-1.

doi: 10.1212/wnl.55.11.1600.

A therapeutic target and biomarker in Friedreich's ataxia

T Sherer, J T Greenamyre

PMID: 11113210
DOI: 10.1212/wnl.55.11.1600

Editorial

A therapeutic target and biomarker in Friedreich's ataxia

T Sherer et al. Neurology. 2000.

. 2000 Dec 12;55(11):1600-1.

doi: 10.1212/wnl.55.11.1600.

Authors

T Sherer, J T Greenamyre

PMID: 11113210
DOI: 10.1212/wnl.55.11.1600

No abstract available

PubMed Disclaimer

Comment on

Oxidative stress in patients with Friedreich ataxia.
Schulz JB, Dehmer T, Schöls L, Mende H, Hardt C, Vorgerd M, Bürk K, Matson W, Dichgans J, Beal MF, Bogdanov MB. Schulz JB, et al. Neurology. 2000 Dec 12;55(11):1719-21. doi: 10.1212/wnl.55.11.1719. Neurology. 2000. PMID: 11113228
Increased levels of plasma malondialdehyde in Friedreich ataxia.
Emond M, Lepage G, Vanasse M, Pandolfo M. Emond M, et al. Neurology. 2000 Dec 12;55(11):1752-3. doi: 10.1212/wnl.55.11.1752. Neurology. 2000. PMID: 11113241 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information